Adsorbed Acellular Pertussis (Tricomponent) DTaP-Hib-ACWY135 Group Meningococcal Conjugate Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adsorbed Acellular Pertussis (Tricomponent) DTaP-Hib-ACWY135 Group Meningococcal Conjugate Vaccine, covering 2025-12-31 to 2025-12-31. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine [Phase 1]